Timo Jan Oberstein

Friedrich-Alexander-Universität Erlangen-Nürnberg

Also affiliated with Universitätsklinikum Erlangen

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain‐Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease”.

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain‐Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease

Journal of Neurochemistry(2025)10.1111/jnc.70313

N/A

0DataRank · unranked

2 citations

Przemysław R. Kac, Fernando C. Ortíz, Thomas K. Karikari, Agnieszka Kulczyńska‐Przybik, Barbara Mroczko +10 more

Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease

The Journal of Prevention of Alzheimer s Disease(2025)10.1016/j.tjpad.2025.100259

N/A

0DataRank · unranked

0 citations

Javier Arbizu, Mercè Boada, Mircea Balasa, Karim Bennys, Marina Boban +47 more